Ticlopidine pretreatment before coronary stenting is associated with sustsained decrease of adverse cardiac events: data from the evaluation of platelet IIb/IIIa inhibitor for stenting (EPISTENT trial)

✍ Scribed by R Steinhubl; S.G Ellis; K Wolski K

• Book ID: 114346698
• Publisher: Elsevier Science
• Year: 2001
• Tongue: English
• Weight: 37 KB
• Volume: 10
• Category: Article
• ISSN: 1062-1458
• DOI: 10.1016/s1062-1458(01)00402-0